AbbVie Inc.
ANTI-EGFR ANTIBODY DRUG CONJUGATES
Last updated:
Abstract:
The invention relates to anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates (ADCs) which inhibit Bcl-xL, including compositions and methods of using said ADCs.
Status:
Application
Type:
Utility
Filling date:
7 Jun 2017
Issue date:
14 Nov 2019